Medicare Enrolled
Dr. Murtaza Bhuriwala, MD
Medical Oncology · Tomball, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bhuriwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhuriwala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhuriwala
Dr. Murtaza Bhuriwala is a medical oncology specialist in Tomball, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bhuriwala performed 93,901 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bhuriwala received a total of $58,254 from 104 pharmaceutical and/or device companies across 1092 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhuriwala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in TX
$58,254 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗93,901
Medicare services
Top 11% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
57,750 | $1 | $3 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
14,300 | $2 | $8 |
| Denosumab injection (Prolia/Xgeva) | 12,240 | $18 | $55 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,100 | $0 | $0 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,495 | $19 | $63 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
574 | $66 | $245 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
545 | $11 | $38 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
495 | $0 | $0 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
197 | $23 | $82 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $95 | $345 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
152 | $95 | $289 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
145 | $101 | $376 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
130 | $50 | $179 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
73 | $52 | $183 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
65 | $57 | $193 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
64 | $1 | $3 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
59 | $1,172 | $5,540 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 55 | $110 | $295 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
54 | $62 | $198 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
45 | $19 | $73 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
45 | $132 | $506 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
42 | $125 | $447 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
31 | $48 | $447 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
30 | $172 | $837 |
| CT scan of chest blood vessels with contrast A CT scan that uses contrast dye to create detailed images of the blood vessels in the chest. |
17 | $128 | $651 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
13 | $62 | $279 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
62.1% high complexity
35.0% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$58,254
Total received (2018-2024)
Avg $8,322/year across 7 years
Top 20% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
104
Companies
1,092
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,632
2023
$3,915
2022
$4,902
2021
$7,245
2020
$4,494
2019
$11,026
2018
$18,040
Payments by company (2024)
Regeneron Pharmaceuticals, Inc.
$3,570
Janssen Biotech, Inc.
$1,962
E.R. Squibb & Sons, L.L.C.
$398
Novartis Pharmaceuticals Corporation
$383
Celgene Corporation
$301
PFIZER INC.
$294
Eisai Inc.
$249
JAZZ PHARMACEUTICALS INC.
$156
ABBVIE INC.
$152
Merck Sharp & Dohme LLC
$101
Gilead Sciences, Inc.
$99
Daiichi Sankyo Inc.
$99
GENZYME CORPORATION
$95
AstraZeneca Pharmaceuticals LP
$75
TerSera Therapeutics LLC
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
Karyopharm Therapeutics Inc.
$68
PUMA BIOTECHNOLOGY, INC.
$57
Boston Scientific Corporation
$54
ADC Therapeutics America, Inc.
$44
Tempus AI, Inc
$43
Incyte Corporation
$38
Secura Bio, Inc.
$37
SOBI, INC
$32
Celltrion USA Inc.
$24
GlaxoSmithKline, LLC.
$21
Aveo Pharmaceuticals, Inc.
$20
Astellas Pharma US Inc
$20
Genentech USA, Inc.
$18
Stemline Therapeutics Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
Fresenius Kabi USA, LLC
$16
Rigel Pharmaceuticals, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Top 3 companies account for 68.7% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$6,155
Novocure Inc.
$5,383
AstraZeneca Pharmaceuticals LP
$4,776
Exelixis Inc.
$3,863
Regeneron Pharmaceuticals, Inc.
$3,656
TESARO, Inc.
$3,232
Celgene Corporation
$2,933
Seattle Genetics, Inc.
$2,862
Janssen Biotech, Inc.
$2,783
Novartis Pharmaceuticals Corporation
$2,523
Genentech USA, Inc.
$2,199
GlaxoSmithKline, LLC.
$2,140
ABBVIE INC.
$2,027
E.R. Squibb & Sons, L.L.C.
$1,445
PFIZER INC.
$1,375
Amgen Inc.
$844
EMD Serono, Inc.
$544
Seagen Inc.
$531
GENZYME CORPORATION
$497
Astellas Pharma US Inc
$471
Eisai Inc.
$454
Merck Sharp & Dohme Corporation
$427
Incyte Corporation
$420
Covis Pharma GmBH
$400
Octapharma USA, Inc.
$302
Gilead Sciences, Inc.
$295
Karyopharm Therapeutics Inc.
$288
Boehringer Ingelheim Pharmaceuticals, Inc.
$275
JAZZ PHARMACEUTICALS INC.
$252
Merck Sharp & Dohme LLC
$239
Daiichi Sankyo Inc.
$222
Ipsen Biopharmaceuticals, Inc
$216
PUMA BIOTECHNOLOGY, INC.
$198
Pharmacyclics LLC, An AbbVie Company
$193
Janssen Pharmaceuticals, Inc
$175
Bayer HealthCare Pharmaceuticals Inc.
$160
Lilly USA, LLC
$155
Verastem, Inc.
$142
MorphoSys, US Inc.
$137
Regeneron Healthcare Solutions, Inc.
$133
AVEO Pharmaceuticals, Inc.
$126
Myriad Genetic Laboratories, Inc.
$121
Boston Scientific Corporation
$104
Stemline Therapeutics Inc.
$98
EISAI INC.
$97
BeiGene USA, Inc.
$96
Teva Pharmaceuticals USA, Inc.
$96
TerSera Therapeutics LLC
$96
Lexicon Pharmaceuticals, Inc.
$94
ADC Therapeutics America, Inc.
$93
Sirtex Medical Inc
$89
Blueprint Medicines Corporation
$86
Agios Pharmaceuticals, Inc.
$77
Coherus Biosciences Inc.
$77
Dendreon Pharmaceuticals LLC
$76
AbbVie Inc.
$73
Adaptive Biotechnologies Corporation
$70
Emmaus Medical, Inc.
$69
Puma Biotechnology, Inc.
$68
Rigel Pharmaceuticals, Inc.
$68
Dova Pharmaceuticals
$56
Taiho Oncology, Inc.
$49
Nestle HealthCare Nutrition Inc.
$46
Myovant Sciences Inc.
$44
Tempus AI, Inc
$43
Biocompatibles, Inc.
$43
CTI BioPharma Corp.
$42
Pharming Healthcare, Inc.
$42
Pharmacosmos Therapeutics Inc.
$41
Secura Bio, Inc.
$37
Sumitomo Pharma America, Inc.
$36
Heron Therapeutics, Inc.
$35
Aveo Pharmaceuticals, Inc.
$35
Jazz Pharmaceuticals Inc.
$34
Helsinn Therapeutics (U.S.), Inc.
$34
SOBI, INC
$32
Inari Medical, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$25
Celltrion USA Inc.
$24
Acceleron Pharma, Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
Immunomedics, Inc.
$22
MEDIVATION FIELD SOLUTIONS LLC
$22
SERVIER PHARMACEUTICALS LLC
$21
Kyowa Kirin, Inc.
$21
Sandoz Inc.
$20
Otsuka America Pharmaceutical, Inc.
$20
Immunocore Limited
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$19
Clovis Oncology, Inc.
$18
ARRAY BIOPHARMA INC
$16
Fresenius Kabi USA, LLC
$16
Mylan Institutional Inc.
$16
G1 Therapeutics, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
AbbVie, Inc.
$15
Organon LLC
$15
Epizyme, Inc.,
$14
Philips Electronics North America Corporation
$14
TAIHO ONCOLOGY, INC.
$13
Shield Therapeutics Inc
$13
TOLMAR Pharmaceuticals, Inc.
$12
Blue Earth Diagnostics Limited
$11
Top 3 companies account for 28.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ABECMA · ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AVYCAZ · AYVAKIT · Adcetris · Alecensa · Aranesp · Axumin · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CHANTIX · CINVANTI · COPIKTRA · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · Columvi · Copiktra · DALVANCE · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Endari · Enhertu · Erleada · FLOWTRIEVER CATHETER · FOTIVDA · Fabhalta · Fulphila · GILOTRIF · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KYMRIAH · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NEXPLANON · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Oncology · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · REBLOZYL · ROLVEDON · RUCONEST · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rubraca · S · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNAGIS · Somatuline Depot · Stimufend · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · THERASPHERE - BIO · THERASPHERE-BIO · TIBSOVO · Tavalisse · Tazverik · Tepmetko · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · Truxima · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vonjo · WATCHMAN Access System · WELIREG · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZARXIO · ZEJULA · ZENPEP · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
13
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bhuriwala is a mixed practice specialist, with above-average Medicare volume (top 11% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bhuriwala experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Bhuriwala performed 57,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bhuriwala receive payments from pharmaceutical companies?
Yes. Dr. Bhuriwala received a total of $58,254 from 104 companies across 1,092 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhuriwala's costs compare to other medical oncologists in Tomball?
Dr. Bhuriwala's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhuriwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Tomball
Browse medical oncologists in Tomball ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Novocure Inc. Payments to Doctors
See all physicians who received payments from Novocure Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology